SCHEMBL3338853

SCHEMBL3338853

CN(C)c1ccc(CNC(=O)c2ccc3c(c2)[nH]c(=O)c2cc(Cl)c(Cl)n23)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRPF1 P55201 1/20 0.49
PARP1 P09874 1/20 0.48
ALDH1A1 P00352 2/20 0.47
KDM4E B2RXH2 2/20 0.47
HTT P42858 2/20 0.47
MAPT P10636 3/20 0.45
CA2 P00918 1/20 0.43
PPARG P37231 1/20 0.42
B3GNT2 Q9NY97 1/20 0.42
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC11 Q96DB2 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
HDAC9 Q9UKV0 1/20 0.41
HDAC5 Q9UQL6 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3339022 0.87 PARP1 (0.54) BRPF1PARP1ALDH1A1KDM4EMAPT
SCHEMBL3336666 0.85 PARP1 (0.66) BRPF1PARP1ALDH1A1LMNAGAA
SCHEMBL3342121 0.85 BRPF1 (0.49) BRPF1PARP1PPARGB3GNT2HDAC4
Trifluoroacetic Acid SCHEMBL3338854 0.77 KMT2A (0.44) BRPF1PARP1ALDH1A1KDM4EMAPT
SCHEMBL3337470 0.74 PARP1 (0.48) PARP1ALDH1A1KDM4EHTTGAA
SCHEMBL3343833 0.74 GRIA1 (0.44) PARP1ALDH1A1KDM4EMAPT
SCHEMBL21091969 0.71 ALDH1A1 (0.88) ALDH1A1KDM4EHTTMAPTCA2
SCHEMBL27404008 0.70 B3GNT2 (0.48) BRPF1PARP1ALDH1A1KDM4EHTT
Hydrochloric Acid SCHEMBL28938255 0.69 ALDH1A1 (0.85) ALDH1A1KDM4EHTTMAPTCA2
SCHEMBL7912491 0.69 GRIN2D (0.55) BRPF1PARP1MAPTB3GNT2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100152180-A1 4-oxo-4,5-dihydropyrrolo[1,2-A)quinoxaline derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP) ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2010-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152180-A1 4-oxo-4,5-dihydropyrrolo[1,2-A)quinoxaline derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP) PARP1, PARP2, PARP4 BRPF1 2845/4885PARP1 1/4885ALDH1A1 185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.